Menu X
Scientists and Clinical Researchers
Healthcare Organizations
About
Partner with Us
News
Contact Us
Novaseek is transforming how scientists and clinical researchers access real world clinical data and human biospecimens to power life sciences R&D in the era of precision medicine and population health management.

Novaseek’s award-winning novel cloud platform, the Clinical Data Network for Research (CDNR), easily interfaces with hospital data sources, and enables researchers to define patient cohorts through population analytics and to obtain biospecimens with longitudinal consented data to advance translational medicine, clinical development and post-launch observational studies.

Our Vision is a world where a clear understanding of real-world patients is central to every stage of life sciences research and drug development.

Contact us now
for your biospecimens and real
world clinical data needs


Contact Us

For Scientists and Clinical Researchers

Novaseek’s award-winning CDNR platform provides access to real world data and supports the ability to define and track patient cohorts based on detailed clinical criteria such as demographics, diagnoses, medications, and lab test results, and supports the collection of biospecimens at various time points for translational medicine, clinical development and post-launch observational studies.

The CDNR platform offers a turn-key intuitive user experience and data interactivity. Typically, patient clinical phenotype data is very limited compared to extremely detailed biological data that can be generated from the biospecimen. CNDR enables researchers to obtain detailed clinical information with every biospecimen, to ensure clinical relevance and significance of every experiment and every study.

Novaseek supports collections of biospecimens and data for oncology, inflammatory, cardiovascular, metabolic/diabetes, auto-immune, endocrine, neurology, and multiple other studies.

The CDNR provides access to biospecimens and data from Novaseek’s network of healthcare organizations. With quick and easy implementation, the CDNR can also be licensed for use at study sponsor’ existing clinical sites.

You can rely on the CDNR platform to generate new insights, increase R&D productivity and decrease project risk in the pursuit of new medical advances.

Novaseek App Demo
 
Watch VideoFind Out More

For Healthcare Organizations

Novaseek Research enables healthcare organizations and consenting patients to share clinical data and biospecimens for research to generate new revenue, and advance medical research and precision medicine.  Novaseek and healthcare organizations within its network use approved protocols and patient consents to ensure the ethical conduct of research and respect for all participants.

Find Out More




About Novaseek

Novaseek is transforming how researchers access clinical data and human biospecimens. CDNR was developed by experts in drug development, hospital operations, and health IT to create a win-win for industry, academia, healthcare partners and patients.



Leadership

Kate Torchilin
Kate Torchilin, PhD, MBA
Chief Executive Officer
Bennett Malbon
Bennett Malbon, MBA
VP of Technology
Steve DiPalma
Steve DiPalma
Chief Financial Officer
Derek Tillemans
Derek Tillemans
VP of Business Development, Healthcare Organizations



Partner with Us

Novaseek Research was founded by a management team with 100+ combined years of experience in life sciences, Health IT and hospital markets. We understand life sciences R&D. We understand clinical data. We understand hospitals and clinical laboratory operations.

Contact us to learn how the Novaseek CDNR platform can become an integral part of your discovery, clinical research, post-launch studies and precision medicine initiatives.

News

Press Releases/Articles Icon

Press Releases & Articles

The Realities of Prceision Medicine

PharmaVoice 2017: “Industry experts discuss the potential of precision medicine and the impact this will have on R&D and commercial operations.

17 Female Health IT Company CEOs to Know

These 17 women are transforming the healthcare industry with technologies designed to enhance efficiency, quality and access of care.

How Community Hospitals Can Bring Cutting-edge Treatments To Their Patients, Build A Reputation For Innovation

Nonacademic institutions have a lot to gain by contributing to work in the life sciences.

Research and Development: Bridging the Gap Between Hospitals, Patients, and Life Sciences

We live in a golden age of medicine. Never before have so many effective treatment options been available to so many people. And precision medicine is bringing new horizons, as well as the promise to further improve disease prevention, treatment, and ultimately find more cures.

The Importance of Community Hospitals’ Participation in Clinical Research

Community hospitals can begin to take on increased roles in clinical research and, in doing so, significantly expand the patient population that can access various studies.

More Press Releases & Articles
RSS Icon

NovaBlog

Aligning Drug Development to More Accurately Reflect the Real-World Patient

With the advance of precision medicine, ensuring that clinical studies more accurately reflect real-world patients needs to be at the heart of drug discovery and development. Historically, one of the reasons that so many studies fail is because patient cohorts are often not defined optimally for the treatment being investigated. Step one in changing this […]

Read More

How Researchers at Biopharma Companies and Academia Can Gain Better Insights into Real-World Clinical Phenotype Data To Improve Clinical Development

Precision medicine is an exciting area of innovation for researchers in academia and industry. It holds the promise of better outcomes for patients, and it is changing the way patients experience disease and treatment. By definition, the patient population for a targeted medicine is smaller than that of the disease category as a whole. Medicines affect patients differently.1 […]

Read More

Visit Novaseek at 2016 AAPS National Biotechnology Conference (May 16-18) at the Sheraton Boston Hotel.

The 2016 AAPS National Biotechnology Conference is the ideal venue to showcase Novaseek’s novel Clinical Data Network for Research (CDNR) platform for accessing the clinical data and biospecimens for research. Please visit us at Booth 403 and learn how Novaseek’s CDNR platform can inform your experiments and biospecimen requests with real world patient phenotype data, […]

Read More

Patients as Partners – Why Biospecimen Consent Matters

We have received many emails about a recent Op-Ed in the New York Times – “Your Cells. Their Research. Your Permission?” By Rebecca Skloot (Dec. 30, 2015). In her piece, Ms. Sloot correctly points out that patient consent is a significant issue regarding the use of biospecimens in research: “Tissues from millions of Americans are […]

Read More

The EHR: Where medicine now takes place

Illinois-based NorthShore University HealthSystem, along with Dartmouth, University of Pennsylvania, Wake Forest Baptist Health System, Medical University of South Carolina, Ochsner Health System, University of Arkansas, and the University of Nebraska are collaborating on “to precision medicine at the point of care, through the EMR.” Focused on neurological disease, this consortium of leading hospitals is […]

Read More
More Blog Posts

Contact Us

Thank you for your interest in Novaseek! To contact our team or request a demo please fill out the form below and we will get back to you as soon as we can. You can also call us at 1-888-632-4311.

Lets Connect

default_rss default_email default_linkedin